BRAF and pleomorphic xanthoastrocytoma: On the molecular level, homozygous deletion of CDKN2A/B (60–95%) and BRAF V600E mutation (60–78%) have emerged as predominant features, each seen in the majority of PXA [4, 8, 12, 20, 21, 29].